 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
4/3/12 Radient Pharmaceuticals Corp. 8-K:2 4/3/12 1:14K Toppan Merrill/FA
3/28/12 Radient Pharmaceuticals Corp. 8-K:2 3/28/12 1:16K Toppan Merrill/FA
2/23/12 Radient Pharmaceuticals Corp. 8-K:2,3,8 2/23/12 1:18K Toppan Merrill/FA
7/25/11 Radient Pharmaceuticals Corp. 8-K:2,9 7/25/11 1:22K Toppan Merrill/FA
6/2/11 Radient Pharmaceuticals Corp. 8-K:2,7,9 6/1/11 2:64K Toppan Merrill/FA
5/11/11 Radient Pharmaceuticals Corp. 8-K:2 5/10/11 1:23K Toppan Merrill/FA
10/15/10 Radient Pharmaceuticals Corp. 8-K:2 10/8/10 1:20K Toppan Merrill/FA
10/5/10 Radient Pharmaceuticals Corp. 8-K:2,8,9 9/29/10 2:60K Toppan Merrill/FA
9/7/10 Radient Pharmaceuticals Corp. 8-K:2,7,9 9/1/10 3:119K Toppan Merrill/FA
8/12/10 Radient Pharmaceuticals Corp. 8-K/A:1,2,9 3/16/10 2:56K Donnelley … Solutions/FA
6/11/10 Radient Pharmaceuticals Corp. 8-K:2 6/10/10 1:23K EDGARdocs/FA
3/16/10 Radient Pharmaceuticals Corp. 8-K:1,2,9 3/16/10 4:204K EDGARdocs/FA
12/16/09 Radient Pharmaceuticals Corp. 8-K:2,9 12/16/09 4:117K EDGARdocs/FA
| ____________ | | ¹ | Filing/Form Type: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. |
|
